News
BSEM
15.00
+3.23%
0.47
Weekly Report: what happened at BSEM last week (0414-0418)?
Weekly Report · 4d ago
BioStem Technologies to Present at the Centri Capital Conference
Barchart · 4d ago
BioStem Technologies Reports Record Revenue in Earnings Call
TipRanks · 04/16 00:07
BioStem Technologies Reports Record Revenue Growth in 2024
TipRanks · 04/15 03:52
Press Release: BioStem Technologies Reports -3-
Dow Jones · 04/14 20:18
BioStem Technologies GAAP EPS of $0.94 beats by $0.60, revenue of $102.87M beats by $16.19M
Seeking Alpha · 04/14 20:17
Weekly Report: what happened at BSEM last week (0407-0411)?
Weekly Report · 04/14 11:36
Weekly Report: what happened at BSEM last week (0331-0404)?
Weekly Report · 04/07 11:36
BioStem Technologies Announces Extension to File 2024 Annual Report with OTC
Barchart · 04/01 15:49
Weekly Report: what happened at BSEM last week (0324-0328)?
Weekly Report · 03/31 11:49
BioStem Announces Notice of Allowance for Two U.S. Patent Applications
Barchart · 03/31 06:00
Weekly Report: what happened at BSEM last week (0317-0321)?
Weekly Report · 03/24 11:36
Weekly Report: what happened at BSEM last week (0310-0314)?
Weekly Report · 03/17 11:48
BioStem Technologies: Building On Advanced Wound Care Needs
Seeking Alpha · 03/17 05:19
Weekly Report: what happened at BSEM last week (0303-0307)?
Weekly Report · 03/10 11:50
Weekly Report: what happened at BSEM last week (0224-0228)?
Weekly Report · 03/03 11:48
Weekly Report: what happened at BSEM last week (0217-0221)?
Weekly Report · 02/24 11:49
Weekly Report: what happened at BSEM last week (0210-0214)?
Weekly Report · 02/17 11:46
Weekly Report: what happened at BSEM last week (0203-0207)?
Weekly Report · 02/10 11:38
Weekly Report: what happened at BSEM last week (0127-0131)?
Weekly Report · 02/03 11:44
More
Webull provides a variety of real-time BSEM stock news. You can receive the latest news about Biostem Tech through multiple platforms. This information may help you make smarter investment decisions.
About BSEM
BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. Its products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AmnioWrap2. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. AmnioWrap2 is a placental-based allograft comprised of unseparated amnion and chorion membranes, including the intact intermediate layer.